Opioids vs. Cannabis

Earlier this year, we shared the results from our Tilray Observational Patient Study (TOPS), a multi-site examination taking place in over 20 medical clinics in 5 provinces, designed to track the impact of medical cannabis on opioid use and other prescription drug use, and quality of life among 1,700 patients across Canada.

“While cannabis itself will not put an end to the current opioid overdose crisis” says Tilray VP of Global Patient Research and Access, “a growing amount of evidence from Canada and the US suggests that it can reduce the therapeutic use of opioids and associated morbidity and mortality by providing patients and physicians with a potentially safer alternative in the treatment of chronic pain.

Learn more about medical cannabis as a potential treatment option:


Read more